[Elsevier] Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Julio.jara Post time 7 day(s) ago | Show all posts |Read mode
Reward10points


Title: Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

DOI: 10.1016/S1470-2045(23)00515-6
ULR: sciencedirect.com/science/article/pii/S260364792400023X?dgcid=author

Thanks,






Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
HambaMeu Post time 7 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    2310

Latest Reply

Return to the list